Federal Watchdog Finds Gaps in DEA, FDA Drug Scheduling Procedures
A recent Government Accountability Office report found that the DEA lacks policies identifying roles, responsibilities, and procedures for scheduling, and...
A recent Government Accountability Office report found that the DEA lacks policies identifying roles, responsibilities, and procedures for scheduling, and...
Gaps in the Food and Drug Administration's (FDA) policies for auditing outside medical device reviewers could allow organizations to continue reviewing...
Chair Bill Cassidy (R-LA) recessed the Senate Health, Education, Labor and Pensions Committee markup on Sept. 24 without a final vote on the No Aid for...
A new U.S. Government Accountability Office (GAO) report on contraceptive coverage compliance found that federal oversight has identified noncompliance...
Veterans from three Pacific nations who served in the U.S. military are struggling to access the health care benefits they earned, and a new Government...
The Senate will examine Heidi Overton's nomination to lead the Food and Drug Administration on September 24...
The Alliance for Quality Improvement and Patient Safety (AQIPS) hired Monument Advocacy to represent its interests in healthcare policy. Monument Advocacy...
The House Energy and Commerce Subcommittee on Health examined 17 bills addressing Medicare payment reform and cybersecurity on September 15, as healthcare...
Patients taking oral cancer drugs face cost-sharing that often exceeds what insurance charges for the same treatment delivered intravenously. A hearing...
The Senate Health, Education, Labor, and Pensions Committee held a nominations hearing on Sept. 16 amid warnings about measles, mental illness and...
Why it matters: The Senate Special Committee on Aging held its first congressional hearing focused on menopause on Sept. 16.
Military families with special-needs dependents may face challenges accessing services through the TRICARE Extended Care Health Option (ECHO) program,...
Illicit fentanyl’s supply chain has shifted without ending the policy challenge described in the Congressional Research Service report China Primer: Illicit...
Congress is examining how to strengthen U.S. generic drug manufacturing as the country remains heavily dependent on foreign pharmaceutical ingredients and...
Invariant LLC ended its representation of the Federation of American Hospitals on July 1, according to a termination filing signed September 10. Invariant...
Health insurance exchange enrollment data sources differ in timing, coverage and definition. A new Congressional Research Services report says exchanges,...
A House Judiciary subcommittee examined health care markets, fraud and competition during a Sept. 14 field hearing in Charlotte, North Carolina, focusing on...
Federal support for drug courts sits at the intersection of criminal justice and public health, according to a new Congressional Research Service report...